CELU earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -0.21. Updated 2026-07-23.
Celularity (CELU) Research Hub
Celularity (CELU) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.75 USD (-23.29%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.21, market cap 0.02B. This hub links to the full technical, earnings and options research available for CELU.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.75 USD (-23.29%) |
| 52-week range | 0.5601 USD – 2.2 USD |
| Trend regime | Range |
| 14-day RSI | 18.8 (Oversold) |
| Trailing P/E | -0.21 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for CELU
Covered Call on CELU: how it works, illustrative setup around the real 0.75 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CELU: how it works, illustrative setup around the real 0.75 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CELU: how it works, illustrative setup around the real 0.75 USD price, max profit/loss, breakeven and when to use it. Educational.
CELU technical analysis: range, last 0.75 USD, RSI 18.8, 52w range 0.5601 USD–2.2 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CELU in?
Celularity (CELU) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CELU in an uptrend or downtrend?
As of 2026-10-26, CELU is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CELU's trailing P/E ratio?
CELU's trailing P/E is -0.21, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does CELU next report earnings?
CELU is next scheduled to report earnings on 2026-08-12.